查看購物車
  • Simplified Chinese
  • English
  • Japanese
全球體外膜氧合（ECMO）設備市場按產品類型、模式、患者類型、應用和最終用戶分類－預測至2030年
市場調查報告書
商品編碼
1858521

全球體外膜氧合（ECMO）設備市場按產品類型、模式、患者類型、應用和最終用戶分類－預測至2030年

ECMO Machines Market by Product (ECMO Machines, Components ), Modality, Patient Type, Application, End User - Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 252 Pages | 訂單完成後即時交付

價格

全球 ECMO 設備市場預計將從 2025 年的 6.5 億美元成長到 2030 年的 8.6 億美元，預測期內複合年成長率為 5.8%。

調查範圍
調查年度 2024-2030
基準年 2024
預測期 2025-2030
單元 10億美元
部分 產品類型、模式、患者類型、應用程式、最終用戶
目標區域 北美、歐洲、亞太地區及其他地區

近年來，體外膜氧合（ECMO）設備已從笨重、人工操作繁瑣的系統發展成為緊湊、自動化且高效的平台。新一代ECMO整合了即時監控、自動流量調節和基於人工智慧的氧合控制功能，減少了持續的人工干預。 Getinge AB和美敦力等主要企業引領可攜式ECMO的創新，促進了院內和院間病患的順利轉運。部分系統現已配備無線連接和雲端基礎監測功能，使專家能夠遠端追蹤患者數據。改進的離心式幫浦和聚甲基戊烯（PMP）氧合器提高了設備的耐用性，並減少了溶血和血栓形成等併發症。

ECMO設備市場-IMG1

此外，抗凝血治療管理的創新降低了出血風險，出血一直是體外膜氧合（ECMO）患者面臨的一大挑戰。這些技術突破提高了病患的生存率，使資源有限的醫院也能更容易使用ECMO，並促進了ECMO在已開發和新興醫療市場的廣泛應用。

依產品類型分類，體外膜氧合（ECMO）設備市場可分為組件和ECMO設備兩部分。 2024年，組件部分在全球ECMO設備市場中佔據最大佔有率。由於急性呼吸窘迫症候群（ARDS）、心臟麻痹和多重器官衰竭的發生率不斷上升，ECMO的使用在全球三級醫院中日益普及。每次ECMO手術都需要消耗氧合器、幫浦、管路、控制器和插管。即使是短期ECMO，氧合器和插管等組件也屬於一次性使用，而幫浦需要精確匹配，並且通常在每次手術後進行升級。疫情後的準備工作將增加ECMO的使用頻率，從而確保組件的穩定週轉。雖然設備本身保持不變，但手術數量的增加將推動組件部分呈指數級成長。

ECMO市場依患者類型分為成人、兒童和新生兒三個細分市場。 2024年，成人患者佔據ECMO設備市場最大的市場。新冠肺炎疫情凸顯了ECMO在治療成人重症呼吸衰竭中的作用。尖峰時段，接受ECMO治療的患者多為嚴重急性呼吸窘迫症候群（ARDS）的成人患者。即使在疫情急性期結束後，許多倖存者仍出現長期肺損傷、肺纖維化和其他呼吸系統併發症，導致重症患者對ECMO的需求增加。新冠肺炎併發症，如心肌炎和病毒性肺炎後遺症，也主要影響成人，從而推動了該年齡層對ECMO的需求。疫情期間，全球醫院擴大了ECMO基礎設施，尤其是在成人加護病房（ICU），這對設備的普及產生了長期影響。由於這種長期影響，2024年成人患者仍將佔據ECMO市場最大的佔有率。

預計在預測期內，北美將佔據體外膜氧合（ECMO）設備市場最大的佔有率。北美，尤其是美國和加拿大，擁有高度發展的醫療保健生態系統，包括一流的醫院、重症監護室和專科醫療中心。這些設施能夠支援ECMO等複雜且資源密集技術。大型三級醫院和教學醫院通常是ECMO手術的中心，其先進的重症監護室和訓練有素的多學科團隊確保了對患者的有效管理。與新興地區相比，北美醫院擁有足夠的財力和基礎設施來投資昂貴的ECMO設備並進行高效維護。此外，數位醫療系統（包括先進的監測工具）的深度整合確保了ECMO的安全管理。這種基礎設施的完善使得ECMO得以大規模應用，提高了治療的可及性並改善了患者的生存率。因此，完善的醫療保健網路在鞏固北美在ECMO設備市場的領先地位方面發揮核心作用。

本報告分析了全球 ECMO 設備市場，並提供了關鍵促進因素和限制因素、競爭格局和未來趨勢的資訊。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 主要發現

  • ECMO設備市場概覽
  • 亞太地區體外膜氧合（ECMO）機市場（按產品和國家分類）（2024 年）
  • ECMO設備市場：地域成長機遇
  • ECMO設備市場，區域組成（2023-2030年）
  • ECMO設備市場：新興國家與已開發國家對比

第5章 市場概覽

  • 介紹
  • 市場動態
    • 促進要素
    • 抑制因素
    • 機會
    • 任務
  • 影響客戶業務的趨勢/顛覆性因素
  • 定價分析
    • 主要企業按類型分類的平均銷售價格
    • 各地區平均銷售價格趨勢
  • 價值鏈分析
  • 供應鏈分析
  • 生態系分析
  • 投資和資金籌措方案
  • 技術分析
    • 主要技術
    • 互補技術
    • 鄰近技術
  • 產業趨勢
    • 在非傳統護理環境中，體外膜氧合（ECMO）的應用日益增加。
    • 體外膜氧合（ECMO）在小兒科和新生兒護理的應用日益廣泛
    • ECMO卓越中心及區域化轉型
    • ECMO模擬訓練與遠距ECMO計畫的發展
  • 專利分析
  • 貿易分析
    • HS編碼901890的進口數據
    • HS編碼901890的出口數據
  • 重大會議和活動（2025-2026）
  • 案例研究分析
  • 監管環境
    • 監管分析
    • 監管機構、政府機構和其他組織
  • 波特五力分析
  • 主要相關利益者和採購標準
  • 未滿足的需求/最終用戶期望
  • 鄰近市場分析
  • 人工智慧/生成式人工智慧對體外膜氧合（ECMO）設備市場的影響
    • 介紹
    • 生成式人工智慧在體外膜氧合（ECMO）設備市場的市場潛力
    • 人工智慧應用案例
    • 主要企業採用人工智慧
    • ECMO設備市場中生成式人工智慧的未來
  • 2025年美國關稅對體外膜氧合（ECMO）設備市場的影響
    • 主要關稅稅率
    • 價格影響分析
    • 對各國/地區的主要影響
    • 對終端用戶產業的影響

第6章 ECMO設備市場：依產品分類

  • 介紹
  • 成分
    • 氧氣發生器
    • 泵浦
    • 控制器
    • 套管
    • 配件
  • 裝置

第7章 ECMO設備市場依模式分類

  • 介紹
  • 靜脈-靜脈體外膜氧合（VV-ECMO）
  • 靜脈-動脈體外膜氧合（VA-ECMO）
  • 動靜脈體外膜氧合（ECMO）

第8章：依病患類型分類的體外膜氧合（ECMO）設備市場

  • 介紹
  • 成年患者
  • 兒科患者
  • 新生

第9章 ECMO設備市場：依應用領域分類

  • 介紹
  • 呼吸系統應用
  • 心臟應用
  • 體外循環心肺復甦

第10章 ECMO設備市場（依最終用戶分類）

  • 介紹
  • 醫院
  • 學術研究機構
  • 專科診所

第11章 ECMO設備市場（按地區分類）

  • 介紹
  • 北美洲
    • 北美宏觀經濟展望
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲宏觀經濟展望
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 亞太宏觀經濟展望
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 亞太其他地區
  • 拉丁美洲
    • 拉丁美洲宏觀經濟展望
    • 巴西
    • 墨西哥
    • 其他拉丁美洲
  • 中東和非洲
  • 海灣合作理事會國家

第12章 競爭格局

  • 概述
  • 主要參與企業的策略/優勢
  • 收入分析（2020-2024）
  • 市佔率分析（2024 年）
  • 企業評估矩陣：主要企業（2024）
  • 公司評估矩陣：Start-Ups/中小企業（2024 年）
  • 公司估值和財務指標
  • 品牌/產品對比
  • 競爭場景

第13章：公司簡介

  • 主要企業
    • GETINGE
    • MEDTRONIC
    • TERUMO CORPORATION
    • FRESENIUS MEDICAL CARE AG
    • LIVANOVA PLC
    • NIPRO
    • WEIGAO GROUP CO., LTD.
    • ABBOTT
    • MICROPORT SCIENTIFIC CORPORATION
    • EUROSETS
  • 其他公司
    • SPECTRUM MEDICAL
    • SENKO MEDICAL INSTRUMENT MFG. CO., LTD.
    • CHALICE MEDICAL LTD.
    • MAGASSIST CO., LTD.
    • BRAILE BIOMEDICA
    • GIZMOMED PRIVATE LIMITED
    • ORIGEN BIOMEDICAL, INC.
    • ABIOMED
    • ANDOCOR
    • JIANGSU STMED TECHNOLOGY CO., LTD.
    • CARDIOQUIP
    • CBM LIFEMOTION
    • CHANGZHOU KANGXIN MEDICAL INSTRUMENTS
    • GENTHERM

第14章附錄

Product Code: MD 3966

The ECMO machines market is projected to reach USD 0.86 billion by 2030 from USD 0.65 billion in 2025, at a CAGR of 5.8% during the forecast period.

Scope of the Report
Years Considered for the Study2024-2030
Base Year2024
Forecast Period2025-2030
Units ConsideredValue (USD billion)
SegmentsGlobal ECMO Machines Market, by Product, Modality, Patient Type, Application, End User
Regions coveredNorth America, Europe, APAC, RoW

In recent years, ECMO machines have evolved from bulky, manual-intensive systems to compact, automated, and highly efficient platforms. Next-generation ECMO integrates real-time monitoring, automated flow adjustments, and artificial intelligence (AI)-driven oxygenation control to reduce the need for constant manual intervention. Companies such as Getinge AB and Medtronic are leading in portable ECMO innovations, enabling smoother inter-hospital and intra-hospital patient transfers. Some systems now feature wireless connectivity and cloud-based monitoring, allowing specialists to track remote patient data. Improved centrifugal pumps and polymethyl pentene (PMP) oxygenators enhance durability and reduce complications such as hemolysis or clot formation.

ECMO Machines Market - IMG1

Moreover, innovations in anticoagulation management reduce the risks of bleeding, a historical challenge for ECMO patients. These technological leaps improve patient survival and make ECMO more user-friendly for hospitals with limited staff, driving wider adoption across developed and emerging healthcare markets.

Based on product, the market of ECMO machines is divided into components and ECMO machines. In 2024, the components segment held the largest share of the global ECMO machines market. With the rising incidence of acute respiratory distress syndrome (ARDS), cardiac arrest, and multi-organ failure, ECMO usage has expanded globally across tertiary hospitals. Each ECMO procedure consumes oxygenators, pumps, tubing sets, controllers, and cannulas. Even in short-term ECMO, components like oxygenators and cannulas are single-use, while pumps require precise compatibility and often get upgraded with each procedure. Post-pandemic preparedness further contributes to higher ECMO use, ensuring steady turnover of components. Unlike the machine itself, which remains constant, the increasing number of procedures fuels exponential growth in the component segment.

Based on patient type, the ECMO market has been categorized into adults, pediatrics and neonates. In 2024, adults held the largest market share in the ECMO machines market. The COVID-19 pandemic highlighted ECMO's role in treating severe respiratory failure in adults. During the peak, most ECMO-supported cases were adults with severe ARDS. Even after the acute pandemic phase, many survivors experienced long-term pulmonary damage, fibrosis, and other respiratory complications that increased ECMO utilization in critical cases. Post-COVID-19 complications like myocarditis and post-viral pneumonia also primarily affect adults, contributing to higher demand for ECMO in this age group. Hospitals worldwide expanded ECMO infrastructure during the pandemic, with a focus on adult ICUs, leaving a long-term impact on equipment adoption. This legacy effect ensured that adults continued to account for the largest ECMO market share in 2024.

North America is expected to account for the largest share of the ECMO machines market during the forecast period. North America, particularly the US and Canada, benefits from a highly advanced healthcare ecosystem equipped with top-tier hospitals, critical care units, and specialized medical centers. These facilities can support sophisticated and resource-intensive technologies such as ECMO. Large tertiary hospitals and academic medical centers often serve as hubs for ECMO procedures, offering advanced ICUs and trained multidisciplinary teams that ensure effective patient management. In contrast to emerging regions, North American hospitals possess the financial and infrastructural capacity to invest in expensive ECMO equipment and maintain it efficiently. Furthermore, strong integration of digital health systems, including advanced monitoring tools, ensures safe ECMO management. This infrastructure readiness makes it feasible for ECMO adoption at scale, enhancing accessibility and increasing survival outcomes. As a result, the well-developed healthcare network plays a central role in reinforcing North America's leadership in the ECMO machines market.

A breakdown of the primary participants (supply-side) for the ECMO machines market referred to in this report is provided below:

  • By Company Type: Tier 1: 34%, Tier 2: 38%, and Tier 3: 28%
  • By Designation: C Level: 26%, Director Level: 35%, and Others: 39%
  • By Region: North America: 17%, Europe: 39%, Asia Pacific: 28%, Latin America: 8%, Middle East & Africa: 3%, GCC Countries: 5%

Prominent players in the ECMO machines market are Fresenius Medical Care AG & Co. KGaA (Germany), Getinge AB (Sweden), Medtronic (Ireland), Terumo Corporation (Japan), and LivaNova PLC (UK).

Research Coverage

The report evaluates the ECMO machines market and estimates the market size and future growth potential based on various segments, including product, modality, patient type, application, end user, and region. The report also includes a competitive analysis of the major players in this market, along with company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will assist the market leader/new entrants with data on the nearest approximations of the revenue numbers for the overall ECMO machines market and the subsegments. The report will assist stakeholders in understanding the competitive landscape and gain further insights into better positioning their businesses and making appropriate go-to-market strategies. The report assists the stakeholders in understanding the market pulse and gives them data on influential drivers, hindrances, obstacles, and opportunities in the market.

This report provides insights into the following points:

  • Analysis of key drivers (Increasing prevalence of cardiovascular and respiratory diseases, Growing adoption of ECMO in lung transplantation procedures), restraints (Complications associated with ECMO, High cost of ECMO procedures), opportunities (Increasing survival rates with ECMO), and challenges (Shortage of skilled professionals, Eligibility issues for ECMO)
  • Product Launches/Innovations: Comprehensive details about product launches and anticipated trends in the global ECMO machines market
  • Market Development: Thorough knowledge and analysis of the profitable rising markets by product, modality, patient type, application, end user, and region
  • Market Diversification: Comprehensive information about newly launched products and services, expanding markets, current advancements, and investments in the global ECMO machines market
  • Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings, and capacities of the major competitors in the global ECMO machines market

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4 MARKET SHARE ESTIMATION
  • 2.5 RESEARCH ASSUMPTIONS
  • 2.6 RESEARCH LIMITATIONS
  • 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 ECMO MACHINES MARKET OVERVIEW
  • 4.2 ASIA PACIFIC: ECMO MACHINES MARKET, BY PRODUCT AND COUNTRY (2024)
  • 4.3 ECMO MACHINES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.4 ECMO MACHINES MARKET, REGIONAL MIX, 2023-2030
  • 4.5 ECMO MACHINES MARKET: EMERGING VS. DEVELOPED ECONOMIES

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing prevalence of cardiovascular and respiratory diseases
      • 5.2.1.2 Growing adoption of ECMO in lung transplantation procedures
      • 5.2.1.3 Rise in ECMO centers worldwide
      • 5.2.1.4 Technological advancements in ECMO machines
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Complications associated with ECMO
      • 5.2.2.2 High cost of ECMO procedures
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Increasing survival rates with ECMO
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Shortage of skilled professionals
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.4 PRICING ANALYSIS
    • 5.4.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY TYPE
    • 5.4.2 AVERAGE SELLING PRICE TREND, BY REGION
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 SUPPLY CHAIN ANALYSIS
  • 5.7 ECOSYSTEM ANALYSIS
  • 5.8 INVESTMENT AND FUNDING SCENARIO
  • 5.9 TECHNOLOGY ANALYSIS
    • 5.9.1 KEY TECHNOLOGIES
      • 5.9.1.1 Advanced oxygenator design
      • 5.9.1.2 High-efficiency blood pumps
    • 5.9.2 COMPLEMENTARY TECHNOLOGIES
      • 5.9.2.1 Advanced hemodynamic monitoring systems
      • 5.9.2.2 Ventilators
    • 5.9.3 ADJACENT TECHNOLOGIES
      • 5.9.3.1 Wearable Artificial Lungs (WALs)
      • 5.9.3.2 Perfusion systems
  • 5.10 INDUSTRY TRENDS
    • 5.10.1 GROWING ADOPTION OF ECMO IN NON-TRADITIONAL CARE SETTINGS
    • 5.10.2 INCREASING USE OF ECMO IN PEDIATRIC AND NEONATAL CARE
    • 5.10.3 SHIFT TOWARD ECMO CENTERS OF EXCELLENCE AND REGIONALIZATION
    • 5.10.4 GROWTH OF ECMO SIMULATION TRAINING AND TELE-ECMO PROGRAMS
  • 5.11 PATENT ANALYSIS
  • 5.12 TRADE ANALYSIS
    • 5.12.1 IMPORT DATA FOR HS CODE 901890
    • 5.12.2 EXPORT DATA FOR HS CODE 901890
  • 5.13 KEY CONFERENCES AND EVENTS, 2025-2026
  • 5.14 CASE STUDY ANALYSIS
    • 5.14.1 CASE STUDY 1: IMPROVED SURVIVAL RATES IN US USING ECMO
    • 5.14.2 CASE STUDY 2: NEONATAL ECMO PROGRAM IN UK
    • 5.14.3 CASE STUDY 3: MOBILE ECMO TRANSPORT SERVICE IN GERMANY
  • 5.15 REGULATORY LANDSCAPE
    • 5.15.1 REGULATORY ANALYSIS
      • 5.15.1.1 North America
        • 5.15.1.1.1 US
        • 5.15.1.1.2 Canada
      • 5.15.1.2 Europe
        • 5.15.1.2.1 Germany
        • 5.15.1.2.2 France
        • 5.15.1.2.3 UK
      • 5.15.1.3 Asia Pacific
        • 5.15.1.3.1 China
        • 5.15.1.3.2 Japan
        • 5.15.1.3.3 India
      • 5.15.1.4 Latin America
        • 5.15.1.4.1 Brazil
        • 5.15.1.4.2 Mexico
      • 5.15.1.5 Middle East & Africa
        • 5.15.1.5.1 South Africa
        • 5.15.1.5.2 GCC Countries
    • 5.15.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.16 PORTER'S FIVE FORCES ANALYSIS
    • 5.16.1 BARGAINING POWER OF SUPPLIERS
    • 5.16.2 BARGAINING POWER OF BUYERS
    • 5.16.3 THREAT OF NEW ENTRANTS
    • 5.16.4 THREAT OF SUBSTITUTES
    • 5.16.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.17 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.17.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.17.2 BUYING CRITERIA
  • 5.18 UNMET NEEDS/END-USER EXPECTATIONS
  • 5.19 ADJACENT MARKET ANALYSIS
  • 5.20 IMPACT OF AI/GEN AI ON ECMO MACHINES MARKET
    • 5.20.1 INTRODUCTION
    • 5.20.2 MARKET POTENTIAL OF GEN AI ON ECMO MACHINES MARKET
    • 5.20.3 AI USE CASES
    • 5.20.4 KEY COMPANIES IMPLEMENTING AI
    • 5.20.5 FUTURE OF GEN AI IN ECMO MACHINES MARKET
  • 5.21 IMPACT OF 2025 US TARIFF ON ECMO MACHINES MARKET
    • 5.21.1 KEY TARIFF RATES
    • 5.21.2 PRICE IMPACT ANALYSIS
    • 5.21.3 KEY IMPACT ON COUNTRY/REGION
      • 5.21.3.1 US
      • 5.21.3.2 Europe
      • 5.21.3.3 Asia Pacific
    • 5.21.4 IMPACT ON END-USE INDUSTRIES

6 ECMO MACHINES MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
  • 6.2 COMPONENTS
    • 6.2.1 OXYGENATORS
      • 6.2.1.1 Significantly less priming volume associated with PMP oxygenators to boost demand
    • 6.2.2 PUMPS
      • 6.2.2.1 Pivotal role played by centrifugal blood pumps in adult extracorporeal life support to support market growth
    • 6.2.3 CONTROLLERS
      • 6.2.3.1 Ability of controllers to allow operators of ECMO circuits to adjust settings as needed to drive demand
    • 6.2.4 CANNULAS
      • 6.2.4.1 Importance of cannulas in optimizing ECMO flows to boost market
    • 6.2.5 ACCESSORIES
  • 6.3 MACHINES
    • 6.3.1 ADVANTAGES SUCH AS TIMELY INTERVENTION IN CASES OF RESPIRATORY AND CARDIAC EMERGENCIES TO FUEL GROWTH

7 ECMO MACHINES MARKET, BY MODALITY

  • 7.1 INTRODUCTION
  • 7.2 VENOVENOUS ECMO
    • 7.2.1 LOWER INCIDENCE OF NEUROLOGIC COMPLICATIONS AND LACK OF ARTERIAL COMPROMISE TO BOOST GROWTH
  • 7.3 VENOARTERIAL ECMO
    • 7.3.1 INCREASING INCIDENCE OF HEART-LUNG FAILURE TO DRIVE GROWTH
  • 7.4 ARTERIOVENOUS ECMO
    • 7.4.1 PORTABILITY OF ARTERIOVENOUS ECMO MACHINES TO DRIVE DEMAND

8 ECMO MACHINES MARKET, BY PATIENT TYPE

  • 8.1 INTRODUCTION
  • 8.2 ADULT PATIENTS
    • 8.2.1 TECHNOLOGICAL ADVANCEMENTS TO DRIVE USE OF ECMO IN ADULT PATIENTS
  • 8.3 PEDIATRIC PATIENTS
    • 8.3.1 RECENT ADVANCES IN ECMO TO BOOST MARKET GROWTH
  • 8.4 NEONATES
    • 8.4.1 INCREASING UTILIZATION OF ECMO TO MANAGE NEONATES WITH CARDIAC AND RESPIRATORY FAILURE TO SUPPORT GROWTH

9 ECMO MACHINES MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
  • 9.2 RESPIRATORY APPLICATIONS
    • 9.2.1 INCREASING CASES OF ACUTE RESPIRATORY DISTRESS SYNDROME, PNEUMONIA, AND INFLUENZA TO SPUR GROWTH
  • 9.3 CARDIAC APPLICATIONS
    • 9.3.1 RISING PREVALENCE OF CARDIOVASCULAR DISEASES WORLDWIDE TO SUPPORT GROWTH
  • 9.4 EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION
    • 9.4.1 GROWING CLINICAL EVIDENCE SUGGESTING IMPROVED SURVIVAL RATES AND NEUROLOGICAL OUTCOMES TO FUEL MARKET

10 ECMO MACHINES MARKET, BY END USER

  • 10.1 INTRODUCTION
  • 10.2 HOSPITALS
    • 10.2.1 GROWING USE OF ECMO FOR MANAGING CRITICAL CONDITIONS TO DRIVE MARKET
  • 10.3 ACADEMIC & RESEARCH INSTITUTIONS
    • 10.3.1 INCREASING MEDICAL COLLEGES AND RESEARCH FACILITIES INVESTING IN ECMO SYSTEMS TO FOSTER GROWTH
  • 10.4 SPECIALTY CLINICS
    • 10.4.1 RISING NEED FOR ADVANCED, LIFE-SAVING INTERVENTIONS TO AID GROWTH

11 ECMO MACHINES MARKET, BY REGION

  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    • 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 11.2.2 US
      • 11.2.2.1 US to account for largest share of North American market
    • 11.2.3 CANADA
      • 11.2.3.1 Implementation of ABF model in Canadian hospitals to drive market growth
  • 11.3 EUROPE
    • 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 11.3.2 GERMANY
      • 11.3.2.1 Increasing volume of ECMO procedures to drive market growth in Germany
    • 11.3.3 FRANCE
      • 11.3.3.1 Rising healthcare spending to drive market growth in France
    • 11.3.4 UK
      • 11.3.4.1 Significant investment in healthcare to support adoption of advanced medical technologies like ECMO
    • 11.3.5 ITALY
      • 11.3.5.1 High burden of CVDs to contribute to growth of ECMO machines market in Italy
    • 11.3.6 SPAIN
      • 11.3.6.1 High adoption of advanced technologies to drive market growth in Spain
    • 11.3.7 REST OF EUROPE
  • 11.4 ASIA PACIFIC
    • 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 11.4.2 JAPAN
      • 11.4.2.1 Favorable healthcare infrastructure in Japan to drive market growth
    • 11.4.3 CHINA
      • 11.4.3.1 Large patient population and government-backed critical care infrastructure expansion to fuel growth
    • 11.4.4 INDIA
      • 11.4.4.1 Growing applications and rising adoption of ECMO to drive market growth in India
    • 11.4.5 SOUTH KOREA
      • 11.4.5.1 Advanced healthcare infrastructure and early ECMO adoption to position South Korea as leading regional market
    • 11.4.6 AUSTRALIA
      • 11.4.6.1 Rising respiratory and cardiac complications, coupled with aging population, to fuel ECMO adoption
    • 11.4.7 REST OF ASIA PACIFIC
  • 11.5 LATIN AMERICA
    • 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 11.5.2 BRAZIL
      • 11.5.2.1 Rising adoption of ECMO as bridge to heart and lung transplantation to drive market growth in Brazil
    • 11.5.3 MEXICO
      • 11.5.3.1 High burden of CVDs in country to drive market growth in Mexico
    • 11.5.4 REST OF LATIN AMERICA
  • 11.6 MIDDLE EAST & AFRICA
    • 11.6.1 INCREASING PREVALENCE OF TARGET DISEASES TO DRIVE MARKET GROWTH IN MIDDLE EAST & AFRICA
    • 11.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 11.7 GCC COUNTRIES
    • 11.7.1 RISING INVESTMENTS IN ADVANCED HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH
    • 11.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

12 COMPETITIVE LANDSCAPE

  • 12.1 OVERVIEW
  • 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 12.3 REVENUE ANALYSIS, 2020-2024
  • 12.4 MARKET SHARE ANALYSIS, 2024
  • 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 12.5.1 STARS
    • 12.5.2 EMERGING LEADERS
    • 12.5.3 PERVASIVE PLAYERS
    • 12.5.4 PARTICIPANTS
    • 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 12.5.5.1 Company footprint
      • 12.5.5.2 Region footprint
      • 12.5.5.3 Product footprint
      • 12.5.5.4 Application footprint
      • 12.5.5.5 End-user footprint
  • 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 12.6.1 PROGRESSIVE COMPANIES
    • 12.6.2 RESPONSIVE COMPANIES
    • 12.6.3 DYNAMIC COMPANIES
    • 12.6.4 STARTING BLOCKS
    • 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
      • 12.6.5.1 Detailed list of key startups/SMEs
      • 12.6.5.2 Competitive benchmarking of startups/SMEs
  • 12.7 COMPANY VALUATION & FINANCIAL METRICS
    • 12.7.1 FINANCIAL METRICS
    • 12.7.2 COMPANY VALUATION
  • 12.8 BRAND/PRODUCT COMPARISON
  • 12.9 COMPETITIVE SCENARIO
    • 12.9.1 PRODUCT LAUNCHES & APPROVALS
    • 12.9.2 DEALS
    • 12.9.3 EXPANSIONS

13 COMPANY PROFILES

  • 13.1 KEY PLAYERS
    • 13.1.1 GETINGE
      • 13.1.1.1 Business overview
      • 13.1.1.2 Products offered
      • 13.1.1.3 Recent developments
        • 13.1.1.3.1 Product launches
        • 13.1.1.3.2 Expansions
      • 13.1.1.4 MnM view
        • 13.1.1.4.1 Right to win
        • 13.1.1.4.2 Strategic choices
        • 13.1.1.4.3 Weaknesses & competitive threats
    • 13.1.2 MEDTRONIC
      • 13.1.2.1 Business overview
      • 13.1.2.2 Products offered
      • 13.1.2.3 MnM view
        • 13.1.2.3.1 Right to win
        • 13.1.2.3.2 Strategic choices
        • 13.1.2.3.3 Weaknesses & competitive threats
    • 13.1.3 TERUMO CORPORATION
      • 13.1.3.1 Business overview
      • 13.1.3.2 Products offered
      • 13.1.3.3 Recent developments
        • 13.1.3.3.1 Deals
        • 13.1.3.3.2 Expansions
      • 13.1.3.4 MnM view
        • 13.1.3.4.1 Right to win
        • 13.1.3.4.2 Strategic choices
        • 13.1.3.4.3 Weaknesses & competitive threats
    • 13.1.4 FRESENIUS MEDICAL CARE AG
      • 13.1.4.1 Business overview
      • 13.1.4.2 Products offered
      • 13.1.4.3 Recent developments
        • 13.1.4.3.1 Deals
      • 13.1.4.4 MnM view
        • 13.1.4.4.1 Right to win
        • 13.1.4.4.2 Strategic choices
        • 13.1.4.4.3 Weaknesses & competitive threats
    • 13.1.5 LIVANOVA PLC
      • 13.1.5.1 Business overview
      • 13.1.5.2 Products offered
      • 13.1.5.3 MnM view
        • 13.1.5.3.1 Right to win
        • 13.1.5.3.2 Strategic choices
        • 13.1.5.3.3 Weaknesses & competitive threats
    • 13.1.6 NIPRO
      • 13.1.6.1 Business overview
      • 13.1.6.2 Products offered
    • 13.1.7 WEIGAO GROUP CO., LTD.
      • 13.1.7.1 Business overview
      • 13.1.7.2 Products offered
    • 13.1.8 ABBOTT
      • 13.1.8.1 Business overview
      • 13.1.8.2 Products offered
      • 13.1.8.3 Recent developments
        • 13.1.8.3.1 Product approvals
    • 13.1.9 MICROPORT SCIENTIFIC CORPORATION
      • 13.1.9.1 Business overview
      • 13.1.9.2 Products offered
    • 13.1.10 EUROSETS
      • 13.1.10.1 Business overview
      • 13.1.10.2 Products offered
  • 13.2 OTHER PLAYERS
    • 13.2.1 SPECTRUM MEDICAL
    • 13.2.2 SENKO MEDICAL INSTRUMENT MFG. CO., LTD.
    • 13.2.3 CHALICE MEDICAL LTD.
    • 13.2.4 MAGASSIST CO., LTD.
    • 13.2.5 BRAILE BIOMEDICA
    • 13.2.6 GIZMOMED PRIVATE LIMITED
    • 13.2.7 ORIGEN BIOMEDICAL, INC.
    • 13.2.8 ABIOMED
    • 13.2.9 ANDOCOR
    • 13.2.10 JIANGSU STMED TECHNOLOGY CO., LTD.
    • 13.2.11 CARDIOQUIP
    • 13.2.12 CBM LIFEMOTION
    • 13.2.13 CHANGZHOU KANGXIN MEDICAL INSTRUMENTS
    • 13.2.14 GENTHERM

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 ECMO MACHINES MARKET: INCLUSIONS AND EXCLUSIONS
  • TABLE 2 STANDARD CURRENCY CONVERSION RATES, 2020-2024
  • TABLE 3 ECMO MACHINES MARKET: RISK ASSESSMENT
  • TABLE 4 ECMO MACHINES MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
  • TABLE 5 AVERAGE COST OF ECMO, BY COUNTRY, 2024 (USD)
  • TABLE 6 AVERAGE SELLING PRICE OF KEY PLAYERS, BY TYPE, 2024 (USD)
  • TABLE 7 AVERAGE SELLING PRICE TREND OF ECMO MACHINES, BY REGION, 2022-2024 (USD)
  • TABLE 8 ECMO MACHINES MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 9 IMPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024 (USD THOUSAND)
  • TABLE 10 EXPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024 (USD THOUSAND)
  • TABLE 11 ECMO MACHINES MARKET: KEY CONFERENCES AND EVENTS, 2025-2026
  • TABLE 12 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 ECMO MACHINES MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP TWO PRODUCTS (%)
  • TABLE 19 KEY BUYING CRITERIA FOR TOP TWO PRODUCTS
  • TABLE 20 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 21 KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR ECMO MACHINES
  • TABLE 22 ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 23 COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 24 COMPONENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 25 EXAMPLES OF OXYGENATORS
  • TABLE 26 OXYGENATORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 27 EXAMPLES OF PUMPS
  • TABLE 28 PUMPS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 29 EXAMPLES OF CONTROLLERS
  • TABLE 30 CONTROLLERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 31 EXAMPLES OF CANNULAS
  • TABLE 32 CANNULAS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 33 EXAMPLES OF ACCESSORIES
  • TABLE 34 ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 35 EXAMPLES OF MACHINES
  • TABLE 36 MACHINES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 37 MACHINES MARKET, BY REGION, 2023-2030 (UNITS)
  • TABLE 38 ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 39 VENOVENOUS ECMO MACHINES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 40 VENOARTERIAL ECMO MACHINES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 41 ARTERIOVENOUS ECMO MACHINES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 42 COMMON INDICATIONS FOR ECMO IN NEONATES, PEDIATRIC PATIENTS, AND ADULT PATIENTS
  • TABLE 43 ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 44 ECMO MACHINES MARKET FOR ADULT PATIENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 45 ECMO MACHINES MARKET FOR PEDIATRIC PATIENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 46 ECMO MACHINES MARKET FOR NEONATES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 47 ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 48 ECMO MACHINES MARKET FOR RESPIRATORY APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 49 ECMO MACHINES MARKET FOR CARDIAC APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 50 ECMO MACHINES MARKET FOR EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 51 ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 52 ECMO MACHINES MARKET FOR HOSPITALS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 53 ECMO MACHINES MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 54 ECMO MACHINES MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 55 ECMO MACHINES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 56 NORTH AMERICA: ECMO MACHINES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 57 NORTH AMERICA: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 58 NORTH AMERICA: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 59 NORTH AMERICA: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 60 NORTH AMERICA: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 61 NORTH AMERICA: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 62 NORTH AMERICA: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 63 US: MACROECONOMIC INDICATORS
  • TABLE 64 US: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 65 US: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 66 US: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 67 US: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 68 US: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 69 US: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 70 CANADA: MACROECONOMIC INDICATORS
  • TABLE 71 CANADA: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 72 CANADA: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 73 CANADA: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 74 CANADA: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 75 CANADA: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 76 CANADA: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 77 EUROPE: ECMO MACHINES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 78 EUROPE: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 79 EUROPE: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 80 EUROPE: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 81 EUROPE: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 82 EUROPE: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 83 EUROPE: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 84 GERMANY: MACROECONOMIC INDICATORS
  • TABLE 85 GERMANY: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 86 GERMANY: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 87 GERMANY: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 88 GERMANY: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 89 GERMANY: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 90 GERMANY: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 91 FRANCE: MACROECONOMIC INDICATORS
  • TABLE 92 FRANCE: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 93 FRANCE: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 94 FRANCE: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 95 FRANCE: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 96 FRANCE: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 97 FRANCE: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 98 UK: MACROECONOMIC INDICATORS
  • TABLE 99 UK: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 100 UK: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 101 UK: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 102 UK: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 103 UK: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 104 UK: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 105 ITALY: MACROECONOMIC INDICATORS
  • TABLE 106 ITALY: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 107 ITALY: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 108 ITALY: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 109 ITALY: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 110 ITALY: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 111 ITALY: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 112 SPAIN: MACROECONOMIC INDICATORS
  • TABLE 113 SPAIN: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 114 SPAIN: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 115 SPAIN: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 116 SPAIN: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 117 SPAIN: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 118 SPAIN: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 119 REST OF EUROPE: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 120 REST OF EUROPE: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 121 REST OF EUROPE: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 122 REST OF EUROPE: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 123 REST OF EUROPE: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 124 REST OF EUROPE: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 125 ASIA PACIFIC: ECMO MACHINES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 126 ASIA PACIFIC: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 127 ASIA PACIFIC: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 128 ASIA PACIFIC: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 129 ASIA PACIFIC: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 130 ASIA PACIFIC: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 131 ASIA PACIFIC: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 132 JAPAN: MACROECONOMIC INDICATORS
  • TABLE 133 JAPAN: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 134 JAPAN: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 135 JAPAN: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 136 JAPAN: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 137 JAPAN: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 138 JAPAN: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 139 CHINA: MACROECONOMIC INDICATORS
  • TABLE 140 CHINA: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 141 CHINA: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 142 CHINA: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 143 CHINA: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 144 CHINA: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 145 CHINA: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 146 INDIA: MACROECONOMIC INDICATORS
  • TABLE 147 INDIA: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 148 INDIA: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 149 INDIA: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 150 INDIA: ECMO MACHINES MARKET, PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 151 INDIA: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 152 INDIA: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 153 SOUTH KOREA: MACROECONOMIC INDICATORS
  • TABLE 154 SOUTH KOREA: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 155 SOUTH KOREA: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 156 SOUTH KOREA: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 157 SOUTH KOREA: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 158 SOUTH KOREA: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 159 SOUTH KOREA: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 160 AUSTRALIA: MACROECONOMIC INDICATORS
  • TABLE 161 AUSTRALIA: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 162 AUSTRALIA: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 163 AUSTRALIA: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 164 AUSTRALIA: ECMO MACHINES MARKET, PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 165 AUSTRALIA: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 166 AUSTRALIA: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 167 REST OF ASIA PACIFIC: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 168 REST OF ASIA PACIFIC: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 169 REST OF ASIA PACIFIC: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 170 REST OF ASIA PACIFIC: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 171 REST OF ASIA PACIFIC: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 172 REST OF ASIA PACIFIC: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 173 LATIN AMERICA: ECMO MACHINES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 174 LATIN AMERICA: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 175 LATIN AMERICA: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 176 LATIN AMERICA: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 177 LATIN AMERICA: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 178 LATIN AMERICA: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 179 LATIN AMERICA: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 180 BRAZIL: MACROECONOMIC INDICATORS
  • TABLE 181 BRAZIL: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 182 BRAZIL: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 183 BRAZIL: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 184 BRAZIL: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 185 BRAZIL: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 186 BRAZIL: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 187 MEXICO: MACROECONOMIC INDICATORS
  • TABLE 188 MEXICO: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 189 MEXICO: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 190 MEXICO: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 191 MEXICO: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 192 MEXICO: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 193 MEXICO: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 194 REST OF LATIN AMERICA: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 195 REST OF LATIN AMERICA: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 196 REST OF LATIN AMERICA: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 197 REST OF LATIN AMERICA: ECMO MACHINES MARKET, PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 198 REST OF LATIN AMERICA: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 199 REST OF LATIN AMERICA: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 200 MIDDLE EAST & AFRICA: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 201 MIDDLE EAST & AFRICA: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 202 MIDDLE EAST & AFRICA: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 203 MIDDLE EAST & AFRICA: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 204 MIDDLE EAST & AFRICA: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 205 MIDDLE EAST & AFRICA: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 206 GCC COUNTRIES: ECMO MACHINES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 207 GCC COUNTRIES: COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 208 GCC COUNTRIES: ECMO MACHINES MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 209 GCC COUNTRIES: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 210 GCC COUNTRIES: ECMO MACHINES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 211 GCC COUNTRIES: ECMO MACHINES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 212 KEY DEVELOPMENTS IN ECMO MACHINES MARKET, JANUARY 2021-SEPTEMBER 2025
  • TABLE 213 ECMO MACHINES MARKET: DEGREE OF COMPETITION
  • TABLE 214 ECMO MACHINES MARKET: REGION FOOTPRINT
  • TABLE 215 ECMO MACHINES MARKET: PRODUCT FOOTPRINT
  • TABLE 216 ECMO MACHINES MARKET: APPLICATION FOOTPRINT
  • TABLE 217 ECMO MACHINES MARKET: END-USER FOOTPRINT
  • TABLE 218 ECMO MACHINES MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
  • TABLE 219 ECMO MACHINES MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, BY REGION AND APPLICATION
  • TABLE 220 ECMO MACHINES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-SEPTEMBER 2025
  • TABLE 221 ECMO MACHINES MARKET: DEALS, JANUARY 2021-SEPTEMBER 2025
  • TABLE 222 ECMO MACHINES MARKET: EXPANSIONS, JANUARY 2021-SEPTEMBER 2025
  • TABLE 223 GETINGE: COMPANY OVERVIEW
  • TABLE 224 GETINGE: PRODUCTS OFFERED
  • TABLE 225 GETINGE: PRODUCT LAUNCHES, JANUARY 2021-SEPTEMBER 2025
  • TABLE 226 GETINGE: EXPANSIONS, JANUARY 2021-SEPTEMBER 2025
  • TABLE 227 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 228 MEDTRONIC: PRODUCTS OFFERED
  • TABLE 229 TERUMO CORPORATION: COMPANY OVERVIEW
  • TABLE 230 TERUMO CORPORATION: PRODUCTS OFFERED
  • TABLE 231 TERUMO CORPORATION: DEALS, JANUARY 2021-SEPTEMBER 2025
  • TABLE 232 TERUMO CORPORATION: EXPANSIONS, JANUARY 2021-SEPTEMBER 2025
  • TABLE 233 FRESENIUS MEDICAL CARE AG: COMPANY OVERVIEW
  • TABLE 234 FRESENIUS MEDICAL CARE AG: PRODUCTS OFFERED
  • TABLE 235 FRESENIUS MEDICAL CARE AG: DEALS, JANUARY 2021-SEPTEMBER 2025
  • TABLE 236 LIVANOVA PLC: COMPANY OVERVIEW
  • TABLE 237 LIVANOVA PLC: PRODUCTS OFFERED
  • TABLE 238 NIPRO: COMPANY OVERVIEW
  • TABLE 239 NIPRO: PRODUCTS OFFERED
  • TABLE 240 WEIGAO GROUP CO., LTD.: COMPANY OVERVIEW
  • TABLE 241 WEIGAO GROUP CO., LTD.: PRODUCTS OFFERED
  • TABLE 242 ABBOTT: COMPANY OVERVIEW
  • TABLE 243 ABBOTT: PRODUCTS OFFERED
  • TABLE 244 ABBOTT: PRODUCT APPROVALS, JANUARY 2021-SEPTEMBER 2025
  • TABLE 245 MICROPORT SCIENTIFIC CORPORATION: COMPANY OVERVIEW
  • TABLE 246 MICROPORT SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 247 EUROSETS: COMPANY OVERVIEW
  • TABLE 248 EUROSETS: PRODUCTS OFFERED
  • TABLE 249 SPECTRUM MEDICAL: COMPANY OVERVIEW
  • TABLE 250 SENKO MEDICAL INSTRUMENT MFG. CO., LTD.: COMPANY OVERVIEW
  • TABLE 251 CHALICE MEDICAL LTD.: COMPANY OVERVIEW
  • TABLE 252 MAGASSIST CO., LTD.: COMPANY OVERVIEW
  • TABLE 253 BRAILE BIOMEDICA: COMPANY OVERVIEW
  • TABLE 254 GIZMOMED PRIVATE LIMITED: COMPANY OVERVIEW
  • TABLE 255 ORIGEN BIOMEDICAL, INC.: COMPANY OVERVIEW
  • TABLE 256 ABIOMED: COMPANY OVERVIEW
  • TABLE 257 ANDOCOR: COMPANY OVERVIEW
  • TABLE 258 JIANGSU STMED TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
  • TABLE 259 CARDIOQUIP: COMPANY OVERVIEW
  • TABLE 260 CBM LIFEMOTION: COMPANY OVERVIEW
  • TABLE 261 CHANGZHOU KANGXIN MEDICAL INSTRUMENTS: COMPANY OVERVIEW
  • TABLE 262 GENTHERM: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 ECMO MACHINES MARKET SEGMENTATION AND REGIONAL SCOPE
  • FIGURE 2 ECMO MACHINES MARKET: RESEARCH DESIGN
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY-SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND-SIDE): BY END USER, DESIGNATION, AND REGION
  • FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION OF GETINGE AB, 2024
  • FIGURE 9 ECMO MACHINES MARKET: SUPPLY-SIDE MARKET SIZE ESTIMATION, 2024
  • FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DYNAMICS, 2025-2030
  • FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 12 ECMO MACHINES MARKET: TOP-DOWN APPROACH
  • FIGURE 13 DATA TRIANGULATION METHODOLOGY
  • FIGURE 14 ECMO MACHINES MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
  • FIGURE 15 ECMO MACHINES MARKET, BY MODALITY, 2025 VS. 2030 (USD MILLION)
  • FIGURE 16 ECMO MACHINES MARKET, BY PATIENT TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 17 ECMO MACHINES MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 18 ECMO MACHINES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 19 GEOGRAPHICAL SNAPSHOT OF ECMO MACHINES MARKET
  • FIGURE 20 GROWING DEMAND FOR INTEGRATED MULTIFUNCTIONAL DEVICES AND EXPANDING ACCESS TO ADVANCED ICUS IN UNDERSERVED REGIONS TO DRIVE MARKET GROWTH
  • FIGURE 21 COMPONENTS SEGMENT TO ACCOUNT FOR LARGEST SHARE OF APAC MARKET IN 2024
  • FIGURE 22 INDIA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 23 NORTH AMERICA TO DOMINATE ECMO MACHINES MARKET
  • FIGURE 24 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
  • FIGURE 25 ECMO MACHINES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 26 ECMO MACHINES MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 27 AVERAGE SELLING PRICE TREND OF ECMO MACHINES, BY REGION, 2022-2024 (USD)
  • FIGURE 28 VALUE CHAIN ANALYSIS: MAJOR VALUE-ADDED DURING MANUFACTURING AND DISTRIBUTION PHASES
  • FIGURE 29 ECMO MACHINES MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 30 ECMO MACHINES MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 31 ECMO MACHINES MARKET: INVESTMENT AND FUNDING SCENARIO, 2019-2023
  • FIGURE 32 ECMO MACHINES MARKET: VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2019-2023
  • FIGURE 33 ECMO MACHINES MARKET: NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019-2023 (USD MILLION)
  • FIGURE 34 ECMO MACHINES MARKET: PATENT ANALYSIS, JANUARY 2015-JULY 2025
  • FIGURE 35 ECMO MACHINES MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 36 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP TWO PRODUCTS
  • FIGURE 37 KEY BUYING CRITERIA FOR TOP TWO PRODUCTS
  • FIGURE 38 NORTH AMERICA: ECMO MACHINES MARKET SNAPSHOT
  • FIGURE 39 ASIA PACIFIC: ECMO MACHINES MARKET SNAPSHOT
  • FIGURE 40 REVENUE ANALYSIS OF KEY PLAYERS IN ECMO MACHINES MARKET, 2020-2024 (USD MILLION)
  • FIGURE 41 MARKET SHARE ANALYSIS OF KEY PLAYERS IN ECMO MACHINES MARKET (2024)
  • FIGURE 42 ECMO MACHINES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 43 ECMO MACHINES MARKET: COMPANY FOOTPRINT
  • FIGURE 44 ECMO MACHINES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 45 EV/EBITDA OF KEY VENDORS
  • FIGURE 46 YEAR-TO-DATE (YTD) PRICE, TOTAL RETURN, AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 47 ECMO MACHINES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 48 GETINGE: COMPANY SNAPSHOT
  • FIGURE 49 MEDTRONIC: COMPANY SNAPSHOT
  • FIGURE 50 TERUMO CORPORATION: COMPANY SNAPSHOT
  • FIGURE 51 FRESENIUS MEDICAL CARE AG: COMPANY SNAPSHOT
  • FIGURE 52 LIVANOVA PLC: COMPANY SNAPSHOT
  • FIGURE 53 NIPRO: COMPANY SNAPSHOT
  • FIGURE 54 WEIGAO GROUP CO., LTD.: COMPANY SNAPSHOT
  • FIGURE 55 ABBOTT: COMPANY SNAPSHOT
  • FIGURE 56 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT